As of 2024-12-15, the EV/EBITDA ratio of Aurinia Pharmaceuticals Inc (AUP.TO) is -15.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AUP.TO's latest enterprise value is 1,926.18 mil CAD. AUP.TO's TTM EBITDA according to its financial statements is -126.05 mil CAD. Dividing these 2 quantities gives us the above AUP.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |